A study Evaluating Multiple dose levels of PF-06882961 in Adults with Type 2 Diabetes Mellitus

In by ECIR

A study Evaluating Multiple dose levels of PF-06882961 in Adults with Type 2 Diabetes Mellitus

  • This field is for validation purposes and should be left unchanged.
clinicaltrials.gov

Eligibility

Inclusion Criteria

Patients with T2DM who are treated with metformin and/or diet and exercise alone
HbA1C ≥ 7% and ≤ 10.5%
Total body weight >50 kg (110 lb) with BMI 24.5 to 45.4 kg/m^2

Exclusion Criteria

Type 1 diabetes
MI, unstable angina, stroke, heart failure, or TIA
Acute pancreatitis or history of chronic pancreatitis
retinopathy and/or macular edema
active liver disease, including chronic active hepatitis B or C
Known history of HIV

Back to Current Studies